🎗️ Cancer Markers
دلالات الأورام
Tumor markers and cancer screening tests
31 tests in this category
AFP (Alpha-Fetoprotein)
Measures alpha-fetoprotein, a tumor marker for liver cancer (hepatocellular carcinoma) and testicular cancer. Also used in prenatal screening for neural tube defects.
ANTI THYROGLOBULIN ANTIBODY; ANTI Tg
This test measures the level of antibodies against thyroglobulin, a protein produced by the thyroid gland. These antibodies can indicate an autoimmune response where your body mistakenly attacks its own thyroid tissue.
Beta-hCG (Tumor Marker)
Measures beta-hCG as a tumor marker for testicular cancer, gestational trophoblastic disease, and certain other cancers. Different from pregnancy beta-hCG testing.
CA 15-3 (Breast Cancer Marker)
Measures CA 15-3 levels, a tumor marker primarily associated with breast cancer. Used for monitoring treatment response and detecting recurrence.
CA 19-9 (Pancreatic Cancer Marker)
Measures CA 19-9 levels, a tumor marker primarily associated with pancreatic cancer. Also elevated in bile duct, gallbladder, and colorectal cancers.
CA 72-4 (Gastric Cancer Marker)
The CA 72-4 test measures the level of a specific protein, a tumor marker, in your blood. It is primarily used to help monitor individuals diagnosed with certain types of cancer, particularly gastric (stomach) cancer. This test helps track the disease's progression or response to treatment.
CA-125 (Ovarian Cancer Marker)
Measures CA-125 protein levels, which can be elevated in ovarian cancer. Also used to monitor treatment response and detect recurrence in ovarian cancer patients.
Cancer Marker Profile
A Cancer Marker Profile is a blood test that measures the levels of various substances (tumor markers) in your blood that can be produced by cancer cells or by the body in response to cancer. While not used for primary diagnosis, these markers can provide valuable information for monitoring cancer progression, treatment effectiveness, or recurrence.
Cancer Marker Screen - Female
This blood test screens for various tumor markers commonly associated with cancers in females. It helps in identifying potential indicators that may suggest the presence of certain cancers, aiding in early detection or monitoring.
Cancer Marker Screen - Male
This blood test screens for various tumor markers commonly associated with cancers in males. It helps in identifying potential indicators that may suggest the presence of certain cancers, aiding in early detection or monitoring.
Cancer Markers Panel (Male)
Comprehensive male cancer screening panel including PSA (prostate), CEA (colorectal), AFP (liver), CA 19-9 (pancreatic), and beta-hCG (testicular). Five key markers in one package.
CEA (Carcinoembryonic Antigen)
Measures CEA, a protein that can be elevated in colorectal, lung, breast, and other cancers. Primarily used for monitoring cancer treatment response and detecting recurrence.
CHROMOGRANIN A
The Chromogranin A test measures the level of a protein released by neuroendocrine cells in your body. It helps assess the activity of these cells, which are found throughout various organs.
Comprehensive Hereditary Cancer Gene Panel 57 ACMG 20 HBOC and 865 Literature Reviewed Genes
This extensive blood test analyzes a large number of genes associated with an increased risk of various hereditary cancers. It helps identify genetic mutations that could predispose you or your family members to certain cancers, allowing for proactive health management.
Comprehensive Hereditary Cancer Panel (154 Genes)
This blood test screens for genetic mutations across 154 genes known to be associated with an increased risk of hereditary cancers. It's designed for individuals concerned about their family history of cancer, offering insights into potential inherited predispositions.
Cyfra 21 - 1, Serum
The Cyfra 21-1 test measures the level of a protein fragment called cytokeratin 19 in your blood serum. This protein is released by certain types of cancer cells and is used as a tumor marker, primarily for monitoring purposes.
HE4 (Human Epididymis Protein-4)
The HE4 test measures the level of Human Epididymis Protein-4 in your blood. This protein can be elevated in certain conditions, particularly in some types of ovarian cancer. It is often used in combination with other markers for risk assessment.
Hereditary Cancer Gene Panel 57 ACMG Genes
This comprehensive genetic test analyzes 57 genes associated with an increased risk of hereditary cancers, following guidelines from the American College of Medical Genetics and Genomics (ACMG). It helps identify inherited genetic mutations that may predispose individuals to various cancers.
Liquidseq Lung cancer panel [72 genes]
This specialized blood test, known as a liquid biopsy, analyzes 72 genes commonly associated with lung cancer. It detects genetic mutations and biomarkers released by cancer cells into the bloodstream, offering a less invasive way to assess the disease.
NGS Colorectal Cancer Panel
This Next-Generation Sequencing (NGS) panel examines a comprehensive set of genes known to be involved in colorectal cancer. It identifies genetic mutations and biomarkers that can impact disease progression and guide treatment decisions.
NGS Lung Cancer Panel
This Next-Generation Sequencing (NGS) Lung Cancer Panel examines tissue samples to detect specific genetic mutations and biomarkers commonly found in lung cancer. It helps characterize the tumor at a molecular level.
NSE Neuron Specific Enolase
This blood test measures the level of Neuron Specific Enolase (NSE), an enzyme found in nerve cells and certain neuroendocrine cells. Elevated levels can sometimes indicate the presence of specific conditions, particularly certain types of cancer.
NSE Neuron Specific Enolase CSF
This test measures Neuron Specific Enolase (NSE) levels in your cerebrospinal fluid (CSF), which surrounds your brain and spinal cord. Elevated NSE in CSF can indicate damage to nerve cells within the central nervous system.
OncoMonitor ® TRM (Liquid biopsy) Liquid Biopsy Test for Longitudinal Cancer Monitoring
This advanced liquid biopsy test is designed for ongoing monitoring of cancer progression and treatment response over time. It analyzes circulating tumor DNA from a blood sample to track changes in your cancer.
OncoRisk (Germline Test) - 74 Genes Hereditary and Familial Cancer Risk Test
The OncoRisk test analyzes 74 genes to identify inherited genetic mutations that increase your risk of developing various cancers throughout your lifetime. This germline test helps understand your predisposition to hereditary and familial cancers.
Oncotype Dx Breast Cancer
The Oncotype Dx Breast Cancer test analyzes specific genes in breast tumor tissue to predict the likelihood of cancer recurrence and the potential benefit of chemotherapy. It provides a personalized recurrence score to guide treatment decisions.
Protein S100
The S100 protein test measures specific proteins released into the bloodstream, primarily from nerve cells and melanocytes. Elevated levels can indicate damage to these cells or certain disease processes. It serves as a biomarker for various conditions.
PSA (Total) - Prostate
Measures Prostate-Specific Antigen, a protein produced by the prostate gland. The primary screening test for prostate cancer and monitoring treatment response.
PSA Free/Total Ratio
Measures both free and total PSA to calculate the ratio. Helps distinguish prostate cancer from benign prostate enlargement when total PSA is in the borderline range (4-10 ng/mL).
PSA PROFILE
The PSA Profile test measures different forms of Prostate-Specific Antigen in your blood. It helps assess prostate health and can be used as a screening tool for prostate conditions. This test provides a more comprehensive view than a total PSA alone.
THYROGLOBULIN (TG)
The Thyroglobulin (TG) test measures the level of a protein produced by the thyroid gland. It is primarily used as a tumor marker, especially after thyroid cancer treatment.